PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

This study is ongoing, but not recruiting participants.

Study NCT00078585 Information provided by Therion Biologics Corporation

First Received: March 1, 2004 Last Updated: July 7, 2005 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given